Blocking the NAD+ biosynthesis enzyme NamPRT for PPM1D-mutant tumors

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer; sarcoma; breast cancer

Inhibiting NamPRT, a nicotinamide adenine dinucleotide (NAD+) biosynthesis enzyme, could treat PPM1D-mutant cancers

Read the full 207 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE